Molecular biological advances have changed our world for the good, and I am the first to jump up and applaud them. But it is equally important that we don’t let the volume of that applause drown out the voices that offer alternative solutions... [
more ]
With the loss of patent protection on so many blockbuster drugs, Big Pharma’s financial outlook is entering a new phase of opportunity. .. [
more ]
by Sandra S. Lee, Baker Botts
In researching our cover story on the sequestration -- or, put in very stark, black-and-white terms, $85 billion in across-the-board cuts to federal government spending -- and how it is expected to affect biomedical research in every state, I was treated to a slew of colorful comparisons by researchers, trade groups and government leaders, as they grapple to explain the hit they will take when the NIH is forced to cut its budget by 5.1 percent, or $1.6 billion, this fiscal year. .. [
more ]
_4.gif&contenttype=gif "INDIGO")
